EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human Aortic Smooth Muscle Cells

Yusuke Higashi iD, Ryan Dashek, Patrice Delafontaine iD, Randy Scott Rector, Bysani Chandrasekar

Cells · 10.10.2024 · 13 (20) · 1673

DOI: 10.3390/cells13201673 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 10.10.2024. Verfasst von Yusuke Higashi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Medicine/Cardiology, Tulane University School of Medicine, New Orleans, LA 70112, USA. Hauptthemen laut MEDLINE: MicroRNAs, GPI-Linked Proteins, Curcumin, Aorta. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, BLRD VA, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Curcumin, a polyphenolic compound derived from the widely used spice Curcuma longa, has shown anti-atherosclerotic effects in animal models and cultured vascular cells. Inflammation is a major contributor to atherosclerosis development and progression. We previously reported that the induction of the proinflammatory molecule TRAF3IP2 (TRAF3 Interacting Protein 2) or inhibition of the matrix metallopeptidase (MMP) regulator RECK (REversion Inducing Cysteine Rich Protein with Kazal Motifs) contributes to pro-oxidant, proinflammatory, pro-mitogenic and pro-migratory effects in response to external stimuli in vascular smooth muscle cells. Here we hypothesized that EF24, a curcumin analog with a better bioavailability and bioactivity profile, reverses interleukin (IL)-18-induced TRAF3IP2 induction, RECK suppression and the proinflammatory phenotype of primary human aortic smooth muscle cells (ASMC). The exposure of ASMC to functionally active recombinant human IL-18 (10 ng/mL) upregulated TRAF3IP2 mRNA and protein expression, but markedly suppressed RECK in a time-dependent manner. Further investigations revealed that IL-18 inhibited both miR-30a and miR-342 in a p38 MAPK- and JNK-dependent manner, and while miR-30a mimic blunted IL-18-induced TRAF3IP2 expression, miR-342 mimic restored RECK expression. Further, IL-18 induced ASMC migration, proliferation and proinflammatory phenotype switching, and these effects were attenuated by TRAF3IP2 silencing, and the forced expression of RECK or EF24. Together, these results suggest that the curcumin analog EF24, either alone or as an adjunctive therapy, has the potential to delay the development and progression of atherosclerosis and other vascular inflammatory and proliferative diseases by differentially regulating TRAF3IP2 and RECK expression in ASMC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsGPI-Linked ProteinsCurcuminAortaMyocytes, Smooth MuscleInterleukin-18PhenotypeHumansAdaptor Proteins, Signal TransducingInflammationCells, Cultured

Stichwörter der Autor:innen

atherosclerosiscell proliferationcurcumininflammationmigrationvascular proliferative diseases

Substanzen

MicroRNAsGPI-Linked ProteinsRECK protein, humanCurcuminInterleukin-18TRAF3IP2 protein, humanAdaptor Proteins, Signal Transducing

Autor:innen und Institutionen

  • Medicine/Cardiology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
  • NextGen Precision Health, University of Missouri, Columbia, MO 65211, USA.
  • Comparative Medicine Program, University of Missouri, Columbia, MO 65211, USA.
  • Research Service, Harry S. Truman Memorial Veterans Hospital, Columbia, MO 65201, USA.
  • Department of Medicine, Division of Gastroenterology and Hepatology, University of Missouri, Columbia, MO 65201, USA.
  • Department of Nutrition and Exercise Physiology, University of Missouri, Columbia, MO 65201, USA.

ORCID-Profile: Yusuke Higashi, Patrice Delafontaine

Förderung

  • NHLBI NIH HHS
  • BLRD VA
  • NIDDK NIH HHS
  • US Department of Veterans Affairs
  • NIAAA NIH HHS
  • NCATS NIH HHS
  • Department of Veteran Affairs
  • National Institutes of Health

Zitieren

APA

Higashi, Y., Dashek, R., Delafontaine, P., Rector, R. S., & Chandrasekar, B. (2024). EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human Aortic Smooth Muscle Cells. Cells, 13(20), 1673. https://doi.org/10.3390/cells13201673

Vancouver

Higashi Y, Dashek R, Delafontaine P, Rector RS, Chandrasekar B. EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human Aortic Smooth Muscle Cells. Cells. 2024;13(20):1673. doi:10.3390/cells13201673

BibTeX
@article{Higashi2024,
  author = {Higashi, Yusuke and Dashek, Ryan and Delafontaine, Patrice and Rector, Randy Scott and Chandrasekar, Bysani},
  title = {EF24, a Curcumin Analog, Reverses Interleukin-18-Induced miR-30a or miR-342-Dependent TRAF3IP2 Expression, RECK Suppression, and the Proinflammatory Phenotype of Human Aortic Smooth Muscle Cells},
  journal = {Cells},
  year = {2024},
  volume = {13},
  number = {20},
  pages = {1673},
  doi = {10.3390/cells13201673}
}
Kostenlos starten →